As of yesterday’s close, we’re off to the 4th worst start to the year on record, with only the pandemic and great depression responsible for greater YTD declines.

Volatility has been high across asset classes, with 10-year yields moving decisively in both directions over the past two weeks.

Currency markets have been equally choppy over this time period, as traders digest which economies are most vulnerable to a more protectionist U.S. regime.

U.S. equity markets have been ugly across the board, though defensive sectors (utes, staples, etc.) have held up better on a relative basis…

… and the same holds true on a factor basis, with a relative underperformance in small cap and relative outperformance in large cap value signalling institutional capital is looking for liquidity.

Canadian equities have outperformed slightly YTD, but have sold off a similar magnitude to U.S. equities since April 2nd.

We looked at ~70 of the most prominent companies in Canada, which on average, have lost nearly 3 turns on earnings in the latest drawdown.

Recent multiple compression is largely driven by Canadian tech names, which have been dealing with headwinds related to data center demand prior to the latest round of tariffs.

Some of the tech sell-off is valuation driven, though there’s likely some expectation for negative forecast revisions from the street.

A good example here is Celestica (CLS), which is off more than 50% from highs with no change to consensus. 50% on multiple compression alone? Unlikely.

We’ll find out soon enough, with Q1 earnings season in the U.S. kicking off this week, and Canada following shortly after.

About Bullpen: Bullpen Finance Inc. publishes content on Canadian markets and provides paid research coverage of select Canadian issuers. Bullpen is paid in cash by covered issuers, does not accept stock or options, does not hold positions in covered securities, and does not conduct investment banking business. Bullpen and LodeRock Advisors Inc. are affiliated; LodeRock provides investor relations services to issuers, some of whom are covered by Bullpen Research. When a post discusses a covered issuer, a specific disclosure appears at the top of the post. This post is published for general information purposes. It is not personalized investment advice and is not tailored to any individual reader’s circumstances. Bullpen is not a registered investment adviser or dealer. For full disclosures, including analyst certification, jurisdictional statements, and conflict of interest policies, please see our Legal & Disclosures section on our website.

You might be interested in…